Skip to main content
. 2013 Oct 18;9:395–402. doi: 10.2147/TCRM.S52291

Figure 2.

Figure 2

Inhibition of the mevalonate pathway by statins and bisphosphonates.

Note: Reproduced from Pazianas M, Compston J, Huang CL-H. Atrial fibrillation and bispho sphonate therapy. J Bone Miner Res. 2010;25:2–10.4 With permission of the American Society for Bone and Mineral Research.

Abbreviation: HMG Co-A, 3-hydroxy-3-methylglutarylcoenzyme A.